As it turns out, he tore his UCL during those five starts and needed season-ending surgery in June of that year. .@Alek_Manoah6 continues to work hard post Tommy ... T.J. Brock, and Landen ...

LGT Fund Management Co Ltd. acquired a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and ...

HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a report published on Thursday morning,Benzinga reports. HC Wainwright currently has a $ ...

United Therapeutics stock opened at $319.96 on Thursday. United Therapeutics has a 12-month low of $221.53 and a 12-month high of $417.82. The company has a market capitalization of $14.28 billion ...

With Samuel leaving for the Commanders, let's take a look at which receivers are left for quarterback Brock Purdy. It looks like Jauan Jennings will be the 49ers new No. 1 receiver, for now.

The United Nations is the world’s principal organization for deliberating matters of peace and security, but its work encompasses far more than peacekeeping and conflict prevention. The UN ...

Leerink analyst Roanna Ruiz lowered the firm’s price target on United Therapeutics (UTHR) to $420 from $430 and keeps an Outperform rating on the shares. United Therapeutics’ Q4 earnings ...

United Therapeutics Corporation beats earnings expectations. Reported EPS is $6.19, expectations were $6.1. Operator: Good morning, and welcome to the United Therapeutics Corporation Fourth ...

Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per ...

Manchester United fans on X are fearing the worst after Rasmus Hojlund was included in the starting XI to face Ipswich Town. The two sides are set to face each other in the Premier League at Old ...

United Therapeutics’ UTHR fourth-quarter 2024 earnings of $6.19 per share beat the Zacks Consensus Estimate of $6.10. Earnings rose 42% year over year on the back of higher product sales.